PAMP
GRNA

Polar Asset Management Partners’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Polar Asset Management Partners’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-475,000
Closed -$4.66M – 1460
2021
Q2 		$4.66M Hold
475,000
– – 0.05% 409
2021
Q1 		$4.6M Buy
+475,000
New +$4.66M 0.05% 370

Other funds holding GRNA

HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Polar Asset Management Partners's GRNA Position: Q3 2021 in Review

Polar Asset Management Partners sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2021, closing a stake of 475,000 shares — an estimated $4.66M sold.

Polar Asset Management Partners first reported a position in GRNA in Q1 2021 and held it in 2 quarters. The position peaked at $4.66M in Q2 2021. 70 funds tracked by Wall St. Rank hold GRNA as of Q3 2021.

  • Polar Asset Management Partners reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2021 after selling out during the quarter.
  • Polar Asset Management Partners sold 475,000 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2021, an estimated $4.66M.
  • Polar Asset Management Partners first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2021 and held it in 2 quarters.
  • Polar Asset Management Partners's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $4.66M in Q2 2021.
  • 70 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2021.

Based on Polar Asset Management Partners's 13F filing for Q3 2021, filed 15 Nov 2021.